Photo by nci from unsplash
VEGF , VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens Click to show full abstract
VEGF , VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens
Keywords:
polymorphisms outcome;
vegfr2 gstm1;
vegf vegfr2;
multiple myeloma;
gstm1 polymorphisms;
outcome multiple
Journal Title: Blood Cancer Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Cancer Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!